Restriction spectrum imaging improves risk stratification in patients with glioblastoma

12Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND AND PURPOSE: ADC as a marker of tumor cellularity has been promising for evaluating the response to therapy in patients with glioblastoma but does not successfully stratify patients according to outcomes, especially in the upfront setting. Here we investigate whether restriction spectrum imaging, an advanced diffusion imaging model, performed after an operation but before radiation therapy, could improve risk stratification in patients with newly diagnosed glioblastoma relative to ADC. MATERIALS AND METHODS: Pre-radiation therapy diffusion-weighted and structural imaging of 40 patients with glioblastoma were examined retrospectively. Restriction spectrum imaging and ADC-based hypercellularity volume fraction (restriction spectrum imaging-FLAIR volume fraction, restriction spectrum imaging-contrast-enhanced volume fraction, ADC-FLAIR volume fraction, ADC-contrastenhanced volume fraction) and intensities (restriction spectrum imaging-FLAIR 90th percentile, restriction spectrum imaging-contrastenhanced 90th percentile, ADC-FLAIR10th percentile, ADC-contrast-enhanced 10th percentile) within the contrast-enhanced and FLAIR hyperintensity VOIs were calculated. The association of diffusion imaging metrics, contrast-enhanced volume, and FLAIR hyperintensity volume with progression-free survival and overall survival was evaluated by using Cox proportional hazards models. RESULTS: Among the diffusion metrics, restriction spectrum imaging-FLAIR volume fraction was the strongest prognostic metric of progression-free survival (P =.036) and overall survival (P =.007) in a multivariate Cox proportional hazards analysis, with higher values indicating earlier progression and shorter survival. Restriction spectrum imaging-FLAIR 90th percentile was also associated with overall survival (P =.043), with higher intensities, indicating shorter survival. None of the ADC metrics were associated with progression-free survival/overall survival. Contrast-enhanced volume exhibited a trend toward significance for overall survival (P =.063). CONCLUSIONS: Restriction spectrum imaging-derived cellularity in FLAIR hyperintensity regions may be a more robust prognostic marker than ADC and conventional imaging for early progression and poorer survival in patients with glioblastoma. However, future studies with larger samples are needed to explore its predictive ability.

Figures

  • Table 1: Patient characteristics
  • Table 2: Results of univariate CPH analyses of the continuous clinical imaging metrics
  • FIG 1. Boxplots of the imaging metrics.
  • Table 3: Results of multivariate CPH analyses of the continuous imaging metrics covaried with resection type
  • FIG 2. Kaplan-Meier curves for the cohort stratified on the basis of the median values for CEvol for PFS (A) and OS (C), and RSI-FLAIRvf for PFS (B) and OS (D).
  • FIG 3. Shown here are the axial T1-postcontrast, FLAIR, ADC, and RSI-cellularity z score maps acquired postsurgery but pre-RT for 2 patients, A and B. The VOI contours are shown in red and green for the CE and FLAIR-HI, respectively. Patient A is a 63-year-old man with a right posterior frontal GBM who underwent subtotal resection. This patient had high RSI cellularity in the FLAIR-HI region. Although there is corresponding ADC hypointensity in this region, it is subtle and inconspicuous. He had a shorter PFS and OS (PFS, 4.2 months; OS, 6.6 months) than patient B. Patient B is a 31-year-oldwomanwith a right frontal GBM. There are no areas of high RSI cellularity or low ADC signal in the FLAIR-HI or CE region. She had a correspondingly longer PFS (PFS, 14.5 months; OS, 19.9 months).

References Powered by Scopus

17415Citations
5267Readers

This article is free to access.

Cited by Powered by Scopus

74Citations
123Readers
Get full text

Imaging in neuro-oncology

47Citations
109Readers

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Krishnan, A. P., Karunamuni, R., Leyden, K. M., Seibert, T. M., Delfanti, R. L., Kuperman, J. M., … White, N. S. (2017). Restriction spectrum imaging improves risk stratification in patients with glioblastoma. American Journal of Neuroradiology, 38(5), 882–889. https://doi.org/10.3174/ajnr.A5099

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘240481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

43%

Researcher 7

30%

Professor / Associate Prof. 4

17%

Lecturer / Post doc 2

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 16

59%

Neuroscience 8

30%

Physics and Astronomy 2

7%

Computer Science 1

4%

Save time finding and organizing research with Mendeley

Sign up for free
0